Perspectives on Postmastectomy Radiation Therapy for Persistent Nodal Disease After Neoadjuvant Chemotherapy: Is Hindsight 20/20?

Grace L. Smith

doi:10.1016/j.ijrobp.2017.07.020

Perspectives on Postmastectomy Radiation Therapy for Persistent Nodal Disease After Neoadjuvant Chemotherapy: Is Hindsight 20/20?

Radiation Oncology

Research output: Contribution to journal › Editorial › peer-review

Original language	English (US)
Pages (from-to)	560-562
Number of pages	3
Journal	International Journal of Radiation Oncology Biology Physics
Volume	99
Issue number	3
DOIs	https://doi.org/10.1016/j.ijrobp.2017.07.020
State	Published - Nov 1 2017

ASJC Scopus subject areas

Radiation
Oncology
Radiology Nuclear Medicine and imaging
Cancer Research

Access to Document

10.1016/j.ijrobp.2017.07.020

Cite this

@article{0f95217f80c24cce8f20dfb30aa1b730,

title = "Perspectives on Postmastectomy Radiation Therapy for Persistent Nodal Disease After Neoadjuvant Chemotherapy: Is Hindsight 20/20?",

author = "Smith, {Grace L.}",

year = "2017",

month = nov,

day = "1",

doi = "10.1016/j.ijrobp.2017.07.020",

language = "English (US)",

volume = "99",

pages = "560--562",

journal = "International Journal of Radiation Oncology Biology Physics",

issn = "0360-3016",

publisher = "Elsevier Inc.",

number = "3",

}

TY - JOUR

T1 - Perspectives on Postmastectomy Radiation Therapy for Persistent Nodal Disease After Neoadjuvant Chemotherapy

T2 - Is Hindsight 20/20?

AU - Smith, Grace L.

PY - 2017/11/1

Y1 - 2017/11/1

UR - http://www.scopus.com/inward/record.url?scp=85031750964&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85031750964&partnerID=8YFLogxK

U2 - 10.1016/j.ijrobp.2017.07.020

DO - 10.1016/j.ijrobp.2017.07.020

M3 - Editorial

C2 - 29280450

AN - SCOPUS:85031750964

SN - 0360-3016

VL - 99

SP - 560

EP - 562

JO - International Journal of Radiation Oncology Biology Physics

JF - International Journal of Radiation Oncology Biology Physics

IS - 3

ER -

Perspectives on Postmastectomy Radiation Therapy for Persistent Nodal Disease After Neoadjuvant Chemotherapy: Is Hindsight 20/20?

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this